SCHEMBL8004119

SCHEMBL8004119

CCCCCn1c(=O)c2c(n(C)c1=O)N(OC=O)CN2C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 3/20 0.40
▸ PDE4A P27815 3/20 0.33
▸ ADORA2A P29274 2/20 0.33
▸ PDE4B Q07343 2/20 0.33
▸ PDE4C Q08493 2/20 0.33
▸ PDE4D Q08499 2/20 0.33
▸ ADORA2B P29275 1/20 0.33
▸ LMNA P02545 5/20 0.31
▸ TP53 P04637 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ HTT P42858 3/20 0.31
▸ ESR1 P03372 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ PMP22 Q01453 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ TSHR P16473 3/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7606573 0.96 ADORA2A (0.36) TNFPDE4AADORA2APDE4BPDE4C
SCHEMBL8666629 0.68 TNF (0.36) TNFADORA2BLMNATP53HTT
Iodide SCHEMBL28472258 0.66 TNF (0.47) TNFPDE4APDE4BPDE4CPDE4D
SCHEMBL31337271 0.63 CYP1A2 (0.36) PDE4AADORA2APDE4BPDE4CPDE4D
Iodide SCHEMBL28469281 0.63 PDE4A (0.32) PDE4APDE4BPDE4CPDE4D
SCHEMBL15946188 0.61 RGS4 (0.48) TNFPDE4AADORA2APDE4BPDE4C
SCHEMBL6239660 0.60 RGS4 (0.50) TNFPDE4AADORA2APDE4BPDE4C
SCHEMBL10336854 0.59 TNF (0.50) TNFPDE4AADORA2APDE4BPDE4C
SCHEMBL12787622 0.59 MGLL (0.52) TNFADORA2BLMNATP53HTT
SCHEMBL4963710 0.59 MGLL (0.52) TNFADORA2BLMNATP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103730-A Amine substituted compounds CELL THERAPEUTICS, INC. (US) 2000-08-15 — — US disclosed
US-6100271-A Therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-08-08 — — US disclosed
US-6043250-A Methods for using therapeutic compounds containing xanthinyl CELL THERAPEUTICS, INC. (US) 2000-03-28 — — US disclosed
US-5807861-A Amine substituted xanthinyl compounds CELL THERAPEUTICS, INC. (US) 1998-09-15 — — US disclosed
US-5807862-A Therapeutic compounds containing pyrimidinyl moieties CELL THERAPEUTICS, INC. (US) 1998-09-15 — — US disclosed
US-5801182-A Amine substituted compounds CELL THERAPEUTICS, INC. (US) 1998-09-01 — — US disclosed
Send feedback